Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Alebund's AP303 Granted FDA Orphan Drug Designation for Autosomal Dominant Polycystic Kidney Disease
Saturday, March 30, 2024Alebund Pharmaceuticals a biopharmaceutical company dedicated to pioneering therapies for renal diseases and related chronic ailments announced today that the US Food and Drug Administration
GenFleet and BeiGene Announce Trial Partnership for Phase Ib/II Study of GFH009 (CDK9 Inhibitor) and BRUKINSA® (Zanubrutinib) Combination Therapy for Diffuse Large B Cell Lymphoma
Friday, March 29, 2024GenFleet Therapeutics a pioneering clinicalstage biotech company focusing on innovative therapies
HUTCHMED Announces Acceptance of Savolitinib sNDA in China for Locally Advanced or Metastatic MET Exon 14 NSCLC, Both in Treatment-Naïve and Previously Treated Patients
Thursday, March 28, 2024HUTCHMED Limited has announced today that the China National Medical Products Administration has
Breakthrough Discovery Aims to Reduce Healthcare Costs Associated with Wound Healing
Thursday, March 28, 2024Researchers have unveiled a significant advancement in comprehending a critical aspect of wound healing particularly relevant in conditions like diabetes and aging which collectively incur healthcare
Astellas' VYLOY™ (zolbetuximab) Receives Regulatory Approval in Japan for Gastric Cancer Therapy
Wednesday, March 27, 2024Astellas Pharma Inc announced on March that Japans Ministry of Health Labour and Welfare has approved VYLOY an anticlaudin monoclonal antibody
Takeda Receives Approval for ADZYNMA® Intravenous Injection 1500 in Japan to Treat Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
Wednesday, March 27, 2024Takeda has announced the approval of ADZYNMA by the Japanese Ministry of Health Labour and Welfare for treating congenital thrombotic thrombocytopenic purpura in individuals aged and above
Biocytogen and ABL Bio Form Partnership to Advance Development of Innovative Bispecific Antibody-Drug Conjugates (ADCs)
Tuesday, March 26, 2024Biocytogen Pharmaceuticals Co Ltd and ABL Bio Co Ltd have recently announced a collaborative partnership to advance the development of bispecific antibodydrug conjugates
DigmBio, Partnered with BioDuro-Sundia, Announces Clearance of DM5167, a Selective PARP1 Inhibitor, for IND by Korea MFDS
Tuesday, March 26, 2024DigmBio a leading biotechnology company headquartered in South Korea and a partner of BioDuroSundia has achieved a significant milestone with the approval of its selective PARP inhibitor for the treatment
Alphamab Oncology Marks Milestone as First Patient Receives Dose in Australian Clinical Trial for Subcutaneous Formulation JSKN033
Tuesday, March 26, 2024Alphamab Oncology has recently announced the commencement of dosing for the first patient in Australia for their clinical trial JSKN of JSKN This compound is a subcutaneous formulation
AriBio Secures Exclusive Marketing Rights for AR1001 to Address Alzheimer's Disease in China Through $770 Million Agreement
Monday, March 25, 2024AriBio Co Ltd recently finalized a substantial contract for AR an investigational drug targeting earlystage Alzheimers disease in China amounting to up to million for exclusive marketing rights
